Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level

Epigenetic age oscillates during the day (WBC-Neu 52 yr old)

Epigenetic age oscillates during the day

Phenotypical states modulate sensitivity and transcriptional reprogramming in patient-derived glioblastoma cells in response to temozolomide and radiation therapy. [array]

Phenotypical states modulate sensitivity and transcriptional reprogramming in patient-derived glioblastoma cells in response to temozolomide and radiation therapy.

Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas

Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology

Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology.

A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugs

The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (Cell lines Methylation)

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer (PDX Methylation)

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer

Novel Bioinformatic Analyses of Somatic Cell Contamination in Sperm Samples

DNA methylation of fibroblasts from one HGPS patient

DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics

Somatic Cell Contamination as an Inhibitor of Proper Sperm Methylation Analysis

Prognostic marker of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial

Epigenetic methylation chip analysis of childhood ependymoma PFA subgroup patient samples [Infinium 450K Methylation Beadchip]

Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: a multicenter study